Study Finds Extended Paxlovid Regimen Ineffective for Long COVID Symptoms

A US randomized controlled trial published in The Lancet Infectious Diseases indicates that an extended Paxlovid regimen, up to 25 days, did not alleviate cognitive issues, autonomic symptoms, or exercise intolerance in adults with long COVID. This research provides crucial insights into long COVID and viral persistence, suggesting that longer Paxlovid courses may not be an effective treatment for these persistent symptoms.